| Hugh E. Black, DVM, Ph.D. |
Preclinical (Safety) |
| Christian G. Bradley |
Regulatory Compliance (GMP) |
| Matthews O. Bradley, Ph.D. |
Preclinical (Disease Models) |
| Charlie Brindley,Ph.D. |
Pharmacokinetics |
| Guy Buckley |
Patents |
| S. Barak Caine,Ph.D. |
Drug Dependency |
| Joyce Chiarenza |
Labeling and Promotional Materials |
| Debbie R. Cosgrove |
Regulatory Compliance (GCP) |
| Roger Croswell, Ph.D. |
Regulatory Strategy |
| Nicola Giacona Dahl, PharmD |
Clinical (Medical Writer) |
| Lynne Douglas |
Clinical Trial Management, Data Management and Biostatistics |
| Richard G. Einig, Ph.D. |
Regulatory Compliance (GMP) |
| Julia Elenbaas, PharmD |
Clinical (Medical Writer) |
| Robert Fowler, M.D. |
Clinical (Safety) |
| H. Guenter Hennings, Ph.D. |
Regulatory (EU) |
| Anthony J. Japour, M.D. |
Clinical (Antivirals) |
| Karen Jervis, Ph.D. |
IP Management and Product Licensing (Biotech) |
| Norman Lavy, M.D. |
Regulatory (US) |
| Anthony Lockett, M.D., Ph.D. |
Clinical (Vaccines) |
| Fiona MacLeod, BS |
Regulatory (EU and US) |
| David Madge, Ph.D. |
Medicinal Chemistry |
| Carol Maxwell |
Pharmacovigilance |
| Ross Maxwell, Ph.D. |
Medical Devices |
| Benard Rushton BVMS, Ph.D., MRCVS, FRCPath |
Toxicology/Pathology |
| Richard Salvador, Ph.D. |
Preclinical (Pharmacology) |
| Herbert Syrowatka, Ph.D. |
Regulatory Compliance (GMP) |
| Thomas N. Thompson, Ph.D. |
Preclinical (ADME) |
| William Jay Treat, Ph.D. |
CMC (API-Biologicals) |
| Mary Treat, MS |
Regulatory Compliance (GMP) |
| David Tweats, Prof., Ph.D., FRCPath, FIBios |
Genotoxicity |
| Laurene Wang-Smith, Ph.D. |
Clinical (ADME) |
| Adrian Weiss, M.D. |
Clinical (Oncology) |